New Japan Approvals Include Tafinlar, Tagrisso
This article was originally published in PharmAsia News
Executive Summary
The latest batch of drug approvals in Japan includes several novel oncology products, some of which have only recently been launched elsewhere, in a sign that applicants and regulators are trying to speed up local access to important new therapies.